Hara F - Search Results

1

Relation of epidermal growth factor receptor, phosphorylated-Akt, and hypoxia-inducible factor-1alpha in non-small cell lung cancers.

Hirami Y, Aoe M, Tsukuda K, Hara F, Otani Y, Koshimune R, Hanabata T, Nagahiro I, Sano Y, Date H, Shimizu N. Hirami Y, et al. Among authors: hara f. Cancer Lett. 2004 Oct 28;214(2):157-64. doi: 10.1016/j.canlet.2004.04.028. Cancer Lett. 2004. PMID: 15363541

2

Less invasive surgery for primary hyperparathyroidism based on preoperative 99mTc-hexakis-2-methoxyisobutylisonitrile imaging findings.

Taira N, Doihara H, Hara F, Shien T, Takabatake D, Takahashi H, Yoshitomi S, Ishibe Y, Shimizu N. Taira N, et al. Among authors: hara f. Surg Today. 2004;34(3):197-203. doi: 10.1007/s00595-003-2687-z. Surg Today. 2004. PMID: 14999529

3

Antitumor effect of gefitinib ('Iressa') on esophageal squamous cell carcinoma cell lines in vitro and in vivo.

Hara F, Aoe M, Doihara H, Taira N, Shien T, Takahashi H, Yoshitomi S, Tsukuda K, Toyooka S, Ohta T, Shimizu N. Hara F, et al. Cancer Lett. 2005 Aug 8;226(1):37-47. doi: 10.1016/j.canlet.2004.12.025. Cancer Lett. 2005. PMID: 16004931

4

Gefitinib, an epidermal growth factor receptor blockade agent, shows additional or synergistic effects on the radiosensitivity of esophageal cancer cells in vitro.

Taira N, Doihara H, Oota T, Hara F, Shien T, Takahashi H, Yoshitomi S, Ishibe Y, Shimizu N. Taira N, et al. Among authors: hara f. Acta Med Okayama. 2006 Feb;60(1):25-34. doi: 10.18926/AMO/30755. Acta Med Okayama. 2006. PMID: 16508686 Free article.

5

Suppression effects of human recombinant tissue inhibitor of metalloproteinases-1(TIMP-1) on tumor proliferation using in vivo treatment model of well-differentiated colon cancer cell line, HT29.

Ohtani Y, Aoe M, Hara F, Tao H, Koshimune R, Hirami Y, Hanabata T, Shimizu N. Ohtani Y, et al. Among authors: hara f. Acta Med Okayama. 2006 Oct;60(5):257-66. doi: 10.18926/AMO/30738. Acta Med Okayama. 2006. PMID: 17072372 Free article.

6

Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.

Koshimune R, Aoe M, Toyooka S, Hara F, Ouchida M, Tokumo M, Sano Y, Date H, Shimizu N. Koshimune R, et al. Among authors: hara f. BMC Cancer. 2007 Jan 12;7:8. doi: 10.1186/1471-2407-7-8. BMC Cancer. 2007. PMID: 17222343 Free PMC article.

7

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.

Mukai H, Saeki T, Aogi K, Naito Y, Matsubara N, Shigekawa T, Ueda S, Takashima S, Hara F, Yamashita T, Ohwada S, Sasaki Y. Mukai H, et al. Among authors: hara f. Cancer Sci. 2016 Oct;107(10):1465-1470. doi: 10.1111/cas.13017. Epub 2016 Sep 15. Cancer Sci. 2016. PMID: 27452985 Free PMC article. Clinical Trial.

8

NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.

Iwamoto T, Hara F, Uemura Y, Mukai H, Watanabe T, Ohashi Y. Iwamoto T, et al. Among authors: hara f. Breast Cancer Res Treat. 2020 Jul;182(2):325-332. doi: 10.1007/s10549-020-05692-5. Epub 2020 May 28. Breast Cancer Res Treat. 2020. PMID: 32462261 Free article. Clinical Trial.

9

The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells.

Ikeda H, Taira N, Hara F, Fujita T, Yamamoto H, Soh J, Toyooka S, Nogami T, Shien T, Doihara H, Miyoshi S. Ikeda H, et al. Among authors: hara f. Breast Cancer Res. 2010;12(3):R43. doi: 10.1186/bcr2598. Epub 2010 Jun 28. Breast Cancer Res. 2010. PMID: 20579400 Free PMC article.

10

The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.

Takabatake D, Kajiwara Y, Ohtani S, Itano Y, Yamamoto M, Kubo S, Ikeda M, Takahashi M, Hara F, Aogi K, Ohsumi S, Ogasawara Y, Nishiyama Y, Hikino H, Matsuoka K, Takahashi Y, Shien T, Taira N, Doihara H. Takabatake D, et al. Among authors: hara f. Breast Cancer. 2018 Nov;25(6):717-722. doi: 10.1007/s12282-018-0877-1. Epub 2018 Jun 11. Breast Cancer. 2018. PMID: 29948957 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page